Logo
Global Electrocardiograph (ECG) Market 2021-2031

Global Electrocardiograph (ECG) Market 2021-2031

Bonafide Trust 03-04-2022 175 Pages
Region : Global Category : Lifescience Medical Devices

Global electrocardiograph (ECG) market will reach $ 13,291.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure. Highlighted with 83 tables and 90 figures, this 175-page report “Global Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Conventional Devices o Resting ECG Devices o Stress ECG Devices • Emerging Devices o Implantable Loop Recorders o Mobile Cardiac Telemetry o Holter Monitors o Cardiac Event Monitors o Smart ECG Monitors • Software & Services Based on Lead Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Lead Type ECG Devices • 3-Lead Type ECG Devices • 5-Lead Type ECG Devices • 6-Lead Type ECG Devices • 12-Lead Type ECG Devices • Other Lead Types By Function, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic ECG Systems • Monitoring ECG Systems By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Portable ECG Systems • Wireless ECG Systems By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Ambulatory Surgical Centers (ASCs) • Home-based Users • Cardiac Centers • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product Type, Lead Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories ACS Diagnostics Biotricity, Inc. BIOTRONIK SE & Co. KG Boston Scientific Corporation CardioComm Solutions, Inc. Cardioline SpA Edan Instruments, Inc. Fukuda Denshi Co., Ltd. General Electric Company Hill-Rom Holdings, Inc. iRhythm Technologies, Inc. Koninklijke Philips N.V. Medtronic plc Mindray Medical International Limited Nihon Kohden Corporation OSI Systems, Inc. Schiller AG Suzuken Co., Ltd. Zoll Medical Corporation (Asahi Kasei Corporation) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services